PEN 203

Drug Profile

PEN 203

Alternative Names: Papirine

Latest Information Update: 29 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cambrex Corporation; CoPharma
  • Developer CoPharma
  • Class Antivirals
  • Mechanism of Action Immunostimulants; Ribonuclease stimulants; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Herpesvirus infections; Human papillomavirus infections

Most Recent Events

  • 30 Sep 1998 A study has been added to the therapeutic trials section
  • 04 May 1998 Phase-II clinical trials for Herpesvirus infections in USA (Topical)
  • 04 May 1998 Phase-II clinical trials for Human papillomavirus infections in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top